About Hospira produtos hospitalares ltda
Hospira Produtos Hospitalares Ltda: A Comprehensive Guide to the Company
Pfizer Inc. (NYSE:PFE) recently announced that it has completed its acquisition of Hospira, Inc., a leading provider of injectable drugs and infusion technologies. The acquisition is expected to strengthen Pfizer's position in the global pharmaceutical market and expand its portfolio of products.
Hospira Produtos Hospitalares Ltda is a subsidiary of Hospira, Inc. that operates in Brazil. The company specializes in the production and distribution of hospital products, including injectable drugs, infusion systems, and medical devices.
In this article, we will provide a comprehensive guide to Hospira Produtos Hospitalares Ltda, including its history, products and services offered, corporate social responsibility initiatives, and future plans.
History
Hospira was founded in 2004 as a spin-off from Abbott Laboratories' hospital products division. The company quickly established itself as a leader in the global pharmaceutical market with its innovative injectable drugs and infusion technologies.
In 2015, Pfizer acquired Hospira for $17 billion dollars. The acquisition allowed Pfizer to expand its portfolio of sterile injectables and biosimilars while also gaining access to Hospira's manufacturing facilities around the world.
Products & Services Offered
Hospira Produtos Hospitalares Ltda offers a wide range of hospital products designed to improve patient outcomes while reducing healthcare costs. Some of their most popular product categories include:
Injectable Drugs: Hospira produces over 200 generic injectable drugs used for pain management, anesthesia induction/sedation/maintenance/analgesia/paralysis/reversal agents; anti-infectives; oncology; cardiovascular; critical care; emergency medicine; neonatology/pediatrics/adults/general surgery/anesthesia/critical care/nutrition/metabolism/endocrinology/gastroenterology/respiratory diseases/rheumatology/immunology/dermatology.
Infusion Systems: Hospira's infusion systems are designed to deliver medication and fluids directly into a patient's bloodstream. The company offers a range of products, including smart pumps, large volume pumps, and syringe pumps.
Medical Devices: Hospira also produces a variety of medical devices used in hospitals and clinics around the world. These include IV catheters, central venous access devices (CVADs), and enteral feeding tubes.
Corporate Social Responsibility Initiatives
Hospira Produtos Hospitalares Ltda is committed to making a positive impact on the communities it serves. The company has implemented several corporate social responsibility initiatives aimed at improving healthcare outcomes while also reducing its environmental footprint.
One of their most notable initiatives is their "Green Initiative," which aims to reduce waste and energy consumption across all of their manufacturing facilities. The program has resulted in significant reductions in water usage, greenhouse gas emissions, and waste generation.
Hospira Produtos Hospitalares Ltda also supports several charitable organizations focused on improving healthcare outcomes in Brazil. These include the Brazilian Cancer Institute (INCA) and the Brazilian Association for Organ Transplantation (ABTO).
Future Plans
As part of Pfizer's global pharmaceutical portfolio, Hospira Produtos Hospitalares Ltda is well-positioned for future growth. The company plans to continue expanding its product offerings while also investing in new technologies that improve patient outcomes.
One area where Hospira Produtos Hospitalares Ltda sees significant potential for growth is biosimilars – generic versions of biologic drugs that have been shown to be just as effective as their brand-name counterparts but at a lower cost. As one of the leading producers of biosimilars globally with over 10 years' experience producing them worldwide since 2009; they plan to continue investing heavily in this area going forward.
Conclusion
Hospira Produtos Hospitalares Ltda is an innovative provider of hospital products and services that is committed to improving patient outcomes while also reducing healthcare costs. With a wide range of injectable drugs, infusion systems, and medical devices, the company is well-positioned for future growth in the global pharmaceutical market.
Through its corporate social responsibility initiatives and commitment to sustainability, Hospira Produtos Hospitalares Ltda is also making a positive impact on the communities it serves. As part of Pfizer's global pharmaceutical portfolio, the company has access to significant resources that will allow it to continue expanding its product offerings and investing in new technologies that improve patient outcomes.